litlas
Log inCreate account

Paulo M. Hoff

Active 2000–2025

83
Papers
20,742
Citations
62
h-index
79
i10-index

Citations

Citations per year for Paulo M. Hoff1991: 1 citations1992: 1 citations1999: 1 citations2000: 1 citations2001: 4 citations2002: 24 citations2003: 23 citations2004: 47 citations2005: 58 citations2006: 64 citations2007: 102 citations2008: 116 citations2009: 109 citations2010: 150 citations2011: 124 citations2012: 119 citations2013: 130 citations2014: 141 citations2015: 130 citations2016: 136 citations2017: 189 citations2018: 168 citations2019: 653 citations2020: 715 citations2021: 722 citations2022: 489 citations2023: 339 citations2024: 501 citations2025: 225 citations2026: 4 citations1993–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,656 citing papers, 19% of this breakdownChina: 921 citing papers, 10.6% of this breakdownItaly: 693 citing papers, 8% of this breakdownUnited Kingdom: 484 citing papers, 5.6% of this breakdownFrance: 443 citing papers, 5.1% of this breakdownGermany: 427 citing papers, 4.9% of this breakdownSpain: 383 citing papers, 4.4% of this breakdownJapan: 356 citing papers, 4.1% of this breakdownNetherlands: 303 citing papers, 3.5% of this breakdownSwitzerland: 210 citing papers, 2.4% of this breakdownCanada: 208 citing papers, 2.4% of this breakdownBelgium: 207 citing papers, 2.4% of this breakdown
0%19%Other 27.6%

Institutions

Fields

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology17%
  • Immunology and Microbiology1.5%
  • Mathematics0.7%
  • Engineering0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other2.4%

Topics

  • Colorectal Cancer Treatments and Studies9.5%
  • Hepatocellular Carcinoma Treatment and Prognosis4.5%
  • Colorectal Cancer Surgical Treatments4.5%
  • Gastric Cancer Management and Outcomes3.4%
  • Cancer Treatment and Pharmacology3.2%
  • HER2/EGFR in Cancer Research2.9%
  • Other72%

Coauthors

All papers

Open in search
  1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Authors: Eric Van Cutsem, Andrés Cervantes, René Adam, Alberto Sobrero, J. Han van Krieken, Dan Aderka, E. Aranda Aguilar, Alberto Bardelli, Al B. Benson, G. Bodoky, Fortunato Ciardiello, André D’Hoore, Eduardo Díaz‐Rubio, Jean‐Yves Douillard, Michel Ducreux, Alfredo Falcone, Axel Grothey, Thomas Gruenberger, Karin Haustermans, Volker Heinemann, Paulo M. Hoff, C.-H. Köhne, Roberto Labianca, Pierre Laurent‐Puig, Brigette Ma, Tim Maughan, Kei Muro, Nicola Normanno, Pia Österlund, Wim J.G. Oyen, Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 cited by 3,449

  2. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    Authors: Sandra M. Swain, David Miles, Sung‐Bae Kim, Young‐Hyuck Im, Seock‐Ah Im, Semiglazov Vf, Eva Ciruelos, Andreas Schneeweiß, Sherene Loi, Estefanía Monturus, Emma Clark, Adam Knott, Eleonora Restuccia, Mark Benyunes, Javier Cortés, Richy Agajanian, Rizvana Ahmad, Bahriye Aktas, Victor Hugo Medeiros Alencar, Dino Amadori, Jurandyr Moreira de Andrade, Fábio Franke, Catia Angiolini, Kenjiro Aogi, Jess F. Armor, Wichit Arpornwirat, L. Assersohn, William Audeh, Walter E. Aulitzky, Sérgio Jobim Azevedo, Maria Alejandra Bartoli, Norberto Batista López, María Inés Bianconi, Laura Biganzoli, Ruemu Birhiray, Marianna Bitiņa, Ron Blachy, Kimberly Blackwell, Rita A. Blanchard, Paulette Blanchet, Ion Boiangiu, B. Bower, Christine Brezden‐Masley, Adam Brufsky, Leanne S. Budde, Priscilla B. Caguioa, Lourdes Calvo, Mario Campone, Robert R. Carroll, Hugo R. Castro, Valorie F. Chan, Veena Charu, Saverio Cinieri, Michael Clemens, Emilio Alba Conejo, Eduardo Côrtes, Bruno Coudert, Eduardo Cronemberger, Daniel de Iracema Gomes Cubero, Shaker R. Dakhil, Brooke Daniel, Neville Davidson, Maria de Fátima Dias Gauí, Susana de la Cruz, María del Pilar, G. Delgado, John Ellerton, César Estuardo, Louis Fehrenbacher, Jean-­Marc Ferrero, Patrick J. Flynn, Małgorzata Foszczyńska‐Kłoda, Sandra Franco, Hirofumi Fujii, Chris Gallagher, Teresa Gamucci, N Giacomi, Miguel Gil Gil, Antonio González-Martı́n, Vera Gorbunova, E. Gotovkin, Nathan Green, Elza Grincuka, Eva‐Maria Grischke, Vincent Hansen, Jeffrey B. Hargis, Maik Hauschild, Roberto Hegg, Carolyn B. Hendricks, Róbert Hermann, Paulo M. Hoff, Jun Horiguchi, Javier Hornedo Muguiro, Stefano Iacobelli, Kenichi Inoue, Gustavo Ismael, Yoshinori Itoh, Dr Hiroji Iwata, D Jendiroba, Rosa Jochim and 122 more - The Lancet Oncology 2020 cited by 898

  3. Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

    Authors: Mônica Samuel Ávila, Silvia Moreira Ayub‐Ferreira, Mauro Rogério de Barros Wanderley, Fátima das Dores Cruz, Sara Michelly Gonçalves Brandão, Vagner Oliveira Carvalho Rigaud, Marília Harumi Higuchi dos Santos, Ludhmila Abrahão Hajjar, Roberto Kalil Filho, Paulo M. Hoff, Marina Sahade, M. Ferrari, Rômulo Leopoldo de Paula Costa, Max S. Mano, Cecília Beatriz Bittencourt Viana Cruz, Maria Cristina Donadio Abduch, Marco Stephan Lofrano‐Alves, Guilherme Veiga Guimarães, Victor Sarli Issa, Márcio Sommer Bittencourt, Edimar Alcides Bocchi - Journal of the American College of Cardiology 2018 cited by 497

  4. Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

    Authors: Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng‐Wong, Katherine Kim, Yoon‐Koo Kang - The Lancet Oncology 2018 cited by 478

  5. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    Authors: J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Yaroslav Shparyk, Paulo M. Hoff, Alberto Sobrero, Pamela Salman, Jin Li, Светлана Проценко, Zev A. Wainberg, Marc Buyse, Karen Afenjar, Vincent Houé, Agathe Garcia, Tomomi Kaneko, Yingjie Huang, S. Khan‐Wasti, Sergio Santillana, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2015 cited by 621

  6. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    Authors: Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, Vincenzo Valentini, Bengt Glimelius, Karin Haustermans, Bernard Nordlinger, Cornelis JH van de Velde, Judith Balmañà, Jarosław Reguła, Irıs D. Nagtegaal, Geerard L. Beets, Dirk Arnold, Fortunato Ciardiello, Paulo M. Hoff, David J. Kerr, C.-H. Köhne, Roberto Labianca, Timothy Price, Werner Scheithauer, Alberto Sobrero, Josep Tabernero, Dan Aderka, Sérgio Barroso, G. Bodoky, Jean‐Yves Douillard, Hesham El Ghazaly, J. Gallardo, A. Garin, Rob Glynne‐Jones, Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 cited by 1,534

  7. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    Authors: Aimery de Gramont, Eric Van Cutsem, Hans‐Joachim Schmoll, Josep Tabernero, Stephen Clarke, Malcolm J. Moore, David Cunningham, Thomas H. Cartwright, J. Randolph Hecht, Fernando Rivera, Seock‐Ah Im, G. Bodoky, Ramón Salazar, Frédérique Maindrault-Goebel, Einat Shacham‐Shmueli, Emilio Bajetta, Martina Makrutzki, Aijing Shang, Thierry André, Paulo M. Hoff - The Lancet Oncology 2012 cited by 526

  8. Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial

    Authors: Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Asna Siddiqui, Sarah Heeson, Astrid Kiermaier, Harrison Macharia, Eleonora Restuccia, Yoon‐Koo Kang - Gastric Cancer 2022 cited by 57

  9. Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases

    Authors: Jean‐Nicolas Vauthey, Timothy M. Pawlik, Dario Ribero, Tsung‐Teh Wu, Daria Zorzi, Paulo M. Hoff, Henry Q. Xiong, Cathy Eng, Gregory Y. Lauwers, Mari Mino–Kenudson, Mauro Risio, Andrea Muratore, Lorenzo Capussotti, Steven A. Curley, Eddie K. Abdalla - Journal of Clinical Oncology 2006 cited by 1,296

  10. Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

    Authors: Anthony D. Yang, Fan Fan, E. Ramsay Camp, George Van Buren, Wenbiao Liu, Ray Somcio, Michael J. Gray, Haiyun Cheng, Paulo M. Hoff, Lee M. Ellis - Clinical Cancer Research 2006 cited by 526

  11. Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study

    Authors: Fernando G. Zampieri, Thiago Gomes Romano, Jorge I. Salluh, Leandro Utino Taniguchi, Pedro Vitale Mendes, Antônio Paulo Nassar, Roberto Costa, William N. Viana, Marcelo O. Maia, Mariza F. A. Lima, Sylas B. Cappi, Alexandre Carvalho, Fernando Vinicius Cesar De Marco, Marcelo S. Santino, Eric Perecmanis, Fabio G. Miranda, Grazielle Viana Ramos, Aline R. Silva, Paulo M. Hoff, Fernando A. Bozza, Márcio Soares - Intensive Care Medicine 2020 cited by 84

  12. Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics

    Authors: Laurent Claret, Pascal Girard, Paulo M. Hoff, Eric Van Cutsem, Klaas P. Zuideveld, Karin Jorga, Jan Fagerberg, René Bruno - Journal of Clinical Oncology 2009 cited by 271

  13. Oxaliplatin-related thrombocytopenia

    Authors: Denis L. Jardim, Christiane de Arruda Rodrigues, Yana Novis, Vanderson Rocha, Paulo M. Hoff - Annals of Oncology 2012 cited by 121

  14. Irinotecan in the treatment of colorectal cancer

    Authors: Charles S. Fuchs, Edith P. Mitchell, Paulo M. Hoff - Cancer Treatment Reviews 2006 cited by 236

  15. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer

    Authors: Rodrigo Ramela Munhoz, Allan Andresson Lima Pereira, André Deeke Sasse, Paulo M. Hoff, Tiffany A. Traina, Clifford A. Hudis, Ricardo José Marques - JAMA Oncology 2015 cited by 161

  16. Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project

    Authors: Katrin Marie Sjoquist, Lindsay A. Renfro, R. John Simes, Niall C. Tebbutt, Stephen Clarke, Michel Seymour, Richard Adams, Tim Maughan, Leonard B. Saltz, Richard M. Goldberg, Hans‐Joachim Schmoll, Eric Van Cutsem, Jean‐Yves Douillard, Paulo M. Hoff, J. Randolph Hecht, Christophe Tournigand, Cornelis J.A. Punt, Miriam Koopman, Herbert I. Hurwitz, Volker Heinemann, Alfredo Falcone, Rainer Porschen, Charles S. Fuchs, Eduardo Díaz‐Rubio, Enrique Aranda, Carsten Bokemeyer, Ioannis Souglakos, Fairooz F. Kabbinavar, Benoist Chibaudel, Jeffrey P. Meyers, Daniel J. Sargent, Aimery de Gramont, John Zalcberg, The Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD) - JNCI Journal of the National Cancer Institute 2017 cited by 144

  17. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia

    Authors: Maristela Pinheiro Freire, Doroti de Oliveira Garcia, Cilmara Polido Garcia, Maria Fernanda Campagnari Bueno, Carlos Henrique Camargo, Adriana Satie Goncalves Kono Magri, Gabriela Rodrigues Francisco, Rodrigo Reghini, Marcus Fraga Vieira, Karim Yaqub Ibrahim, F. Rossi, Ludhmila Abrahão Hajjar, Anna S. Levin, Paulo M. Hoff, Lígia Câmera Pierrotti, Edson Abdala - Clinical Microbiology and Infection 2015 cited by 122

  18. Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

    Authors: Paulo M. Hoff, Rafat Ansari, Gerald Batist, John V. Cox, Walter Kocha, Mario Kuperminc, Jean A. Maroun, David Walde, Charles Weaver, Evelyn B. Harrison, Hans Ulrich Burger, B Osterwalder, A. Wong, Ralf Wong - Journal of Clinical Oncology 2001 cited by 1,139

  19. Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

    Authors: Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris, Robert A. Wolff, Cathy Eng, Katrina Y. Glover, R. Adinin, Michael J. Overman, V VALERO, Sijin Wen, Christopher H. Lieu, Shaoyu Yan, Hai T. Tran, Lee M. Ellis, James L. Abbruzzese, John V. Heymach - Journal of Clinical Oncology 2009 cited by 487

  20. The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment

    Authors: Louise C. Connell, José Maurício Mota, Maria Ignez Braghiroli, Paulo M. Hoff - Current Treatment Options in Oncology 2017 cited by 242

  21. Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

    Authors: Michael P. Chu, J. Randolph Hecht, Dennis J. Slamon, Zev A. Wainberg, Yung‐Jue Bang, Paulo M. Hoff, Alberto F. Sobrero, Shukui Qin, Karen Afenjar, Vincent Houé, Karen L. King, Sheryl Koski, Karen Mulder, Julie Price Hiller, Andrew Scarfe, Jennifer L. Spratlin, Yingjie Huang, S. Khan‐Wasti, Neil Chua, Michael B. Sawyer - JAMA Oncology 2016 cited by 106

  22. Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Injury

    Authors: Michael J. Overman, Dipen M. Maru, Chusilp Charnsangavej, Evelyn Loyer, Huamin Wang, Priyanka Pathak, Cathy Eng, Paulo M. Hoff, Jean‐Nicolas Vauthey, Robert A. Wolff, Scott Kopetz - Journal of Clinical Oncology 2010 cited by 236

  23. Bevacizumab: overview of the literature

    Authors: Maria Ignez Braghiroli, Jorge Sabbaga, Paulo M. Hoff - Expert Review of Anticancer Therapy 2012 cited by 98

  24. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

    Authors: Jim Cassidy, Chris Twelves, Eric Van Cutsem, Paulo M. Hoff, Emilio Bajetta, Michael Boyer, R. Bugat, Ulrich Bürger, A. Garin, Ullrich Graeven, J. McKendrick, Jean A. Maroun, John L. Marshall, B Osterwalder, G. Pérez-Manga, R. Rosso, P. Rougier, Richard L. Schilsky - Annals of Oncology 2002 cited by 524